| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | -900,8 € | -109.6% | 9,4 k € | |
| EBITDA | -924,3 € | -110.5% | 8,8 k € | |
| Operating profit | -924,3 € | -110.5% | 8,8 k € | |
| Profit/loss | -264,2 € | -104.8% | 5,5 k € | |
| Equity | 109,7 k € | -0.2% | 110,0 k € | |
| Total assets | 109,9 k € | -6.0% | 116,9 k € | |
| Cash | 106,6 k € | +6.0% | 100,6 k € | |
| Debts | 219,1 € | -96.6% | 6,5 k € | |
Source: Belgian Official Gazette
Private limited company · Waterloo · incorporated on 25/03/2014
Private limited company loss-making in the latest fiscal year. Cash position rising (+6.0%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
DELANCEY is a Private limited company incorporated in 2014. Its main activity is: Other human health activities. Its registered office is in Waterloo.